Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.
Artificial human organs, or organ-on-chip technologies, simulate a whole organ’s cell make up and physiology. They act as alternatives to animal models in drug safety testing, but until now they have not been used to test how infectious diseases interact with the organs.
Our work represents the next frontier in the use of this technology.
Dr Marcus Dorner Lead author
Now, researchers from Imperial are using this technology to determine how pathogens interact with artificial organs. They hope it will help us to better understand the resulting disease and develop new treatments.
In particular, the team used an artificial liver – originally developed at MIT, the University of Oxford, and biotechnology company CN Bio Innovations – and tested its response to hepatitis B virus infection.
Dr Marcus Dorner, lead author from Imperial’s Department of Medicine, said: “This is the first time that organ-on-a-chip technology has been used to test viral infections. Our work represents the next frontier in the use of this technology. We hope it will ultimately drive down the cost and time associated with clinical trials, which will benefit patients in the long run.”
Opportunities for future drug development
Hepatitis B virus is currently incurable, and affects over 257 million people worldwide. Development of a cure has been slow because there is no model system in which to test potential therapies.
However, the Imperial team showed that the liver-on-a-chip technology could be infected with hepatitis B virus at physiological levels and had similar biological responses to the virus as a real human liver, including immune cell activation and other markers of infection. In particular, this platform uncovered the virus’s intricate means of evading inbuilt immune responses – a finding which could be exploited for future drug development.
Although this technology is in its early stages, the researchers suggest that it might eventually enable patients to have access to new types of personalised medicine. Rather than using generic cells lines, doctors in the future could potentially use cells from an actual patient and test how they would react to certain drugs for their infection, which may make treatments more targeted and effective.
The benefits of using organs-on-chips
Organs-on-chips house live human cells on scaffolds that are physiologically, mechanically, and structurally similar to the emulated organ. Drugs or viruses are passed through the cells via tubes that simulate blood flow through the body. The living cells used in tests last much longer on the chip than in traditional laboratory methods, and require lower infection doses compared to traditionally used model systems.
Hepatitis B is very infectious and causes liver cancer and cirrhosis. Thus, the researchers say, it was the best virus to use for the first test as its interactions with the immune system and liver cells are complex, but with devastating consequences for the tissues.
Dr Dorner said: “Once we begin testing viruses and bacteria on other artificial organs, the next steps could be to test drug interaction with the pathogens within the organ-on-chip environment.”
Other organs-on-chips currently in use include the heart, kidneys, and lungs. The authors say using these artificial organs for human pathogens could help researchers to better understand the mechanisms of infectious disease, and to observe how the virus and cells in the organ interact. This could lead to new drugs and treatments for a number of diseases affecting different organs in the future.
Learn more: Organ-on-chip technology enters next stage as experts test hepatitis B virus
The Latest on: Artificial human organs
[google_news title=”” keyword=”Artificial human organs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial human organs
- Parents of boy whose heart stopped for 19 hours were stunned when it started beating againon May 9, 2024 at 11:35 am
The family of a 4-year-old boy whose heart had stopped beating hours earlier gathered at Children’s Hospital Colorado last month to say their final goodbyes to Cartier McDaniel.Some slept in the ...
- JP Morgan CEO Mary Callahan Erdoes says 'curiosity' will be the most important human trait in the age of AIon May 9, 2024 at 10:03 am
JPMorgan's CEO of Asset & Wealth Management, Mary Callahan Erdoes, spoke with BI about AI.She believes curiosity is the key trait humans need to harness the potential of AI."It has to be okay to ask ...
- JP Morgan's Mary Callahan Erdoes says 'curiosity' will be the most important human trait in the age of AIon May 9, 2024 at 9:07 am
One of JPMorgan's top execs believes a single human trait will define the winners of the AI age ... and academia discussed the challenges and opportunities of artificial intelligence. JPMorgan has ...
- New fluidic system advances development of artificial blood vessels and biomedicine applicationson May 9, 2024 at 7:05 am
Nature consistently inspires engineering applications. Recently, a group of researchers from the Faculty of Engineering at the University of Hong Kong (HKU) drew new inspiration from the vascular ...
- Forbes Daily: Uber’s Short Profitable Streak Comes To A Sudden Stopon May 9, 2024 at 5:04 am
Thursday's edition of Forbes Daily covers Uber and Shopify see stocks fall, AI in the office, Tesla's lidar orders and Musk's xAI funding, new streaming bundle and more.
- Two studies aim to fight cancer with artificial cellson May 5, 2024 at 5:00 pm
The artificial cells will interact with organoids, three-dimensional aggregates of cells normally used in research to replicate human tissues and organs as miniaturized and simplified models, which ...
- Opinion: It’s time to stop product and science testing on animalson April 24, 2024 at 3:44 am
Science has given us many marvels. Electricity immediately springs to mind, as does the telephone. The remarkable ease with which we’re able to trace our ancestry is utterly astounding, and ...
- Together with Missouri S&T, Saint Louis University Researchers Use Artificial Intelligence to Improve Kidney Transplant Processon November 18, 2022 at 3:16 pm
Mark Schnitzler, Ph.D., professor of surgery at SLU’s School of Medicine, says using AI tools to facilitate organ utilization is new. Currently, the work processes are very human-intensive. “The big ...
- Tissue engineeringon December 1, 2021 at 5:49 am
other tissues and organs will see their day. A great deal of excitement in clinical circles is that of developing artificial human thyroid tissues which are capable of producing T cells ...
- Mice Develop Inside An Artificial Wombon April 30, 2021 at 3:39 am
Although people-growing is probably a long way off, mice can now mostly develop inside an artificial uterus (try ... of people die every year waiting for organ transplants, and scientists are ...
via Bing News